Metabolic and hemodynamic effects of intravenous methylprednisolone pulse therapy in patients with thyroid eye disease: a prospective cohort study

Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for active moderate-to-severe thyroid eye disease (TED). However, systemic corticosteroids may affect blood pressure, glucose metabolism, and liver enzymes, requiring clinical monitoring. To evaluate changes in blood pressure, random blood glucose, and serum transaminase levels in TED patients receiving IVMP pulse therapy. A prospective cohort study was conducted on 30 TED patients treated with IVMP according to the